Interaction of Tumour with Host Stroma in Hepatocellular Carcinoma

作者: D.S.R. Lockwood , D.C. Gotley

DOI: 10.1007/1-4020-3414-8_9

关键词:

摘要: Hepatocellular cancer has been observed to progress in distinct morphological patterns: expanding or infiltrating, and these are ultimately associated with clinical outcomes. Tumor encapsulation is a particular phenomenon that attracted attention because of potential insights be gained about tumor stromal interactions. Much the current knowledge biology liver stroma comes from study cirrhosis, which form chronic wound healing, most hepatocellular cancers develop on background hepatic cirrhosis. Hepatic stellate cells myofibroblasts responsible for extracellular matrix turnover liver, collagen around encapsulated tumors. Since tumors have better prognosis than non-encapsulated tumors, it proposed host response presence tumor, kind defense mechanism. It unlikely as simple this, since capsule may reflect inherently attenuated invasive properties tumor. This chapter reviews interactions between stroma, reveals complex model tumor-host interactions, yet translate opportunities therapeutic benefit.

参考文章(79)
Lun-Xiu Qin, Zhao-You Tang, The prognostic significance of clinical and pathological features in hepatocellular carcinoma World Journal of Gastroenterology. ,vol. 8, pp. 193- 199 ,(2002) , 10.3748/WJG.V8.I2.193
Ikuo Saiki, Hiroaki Sakurai, Mitsuhiro Matsuo, ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, shows antimetastatic activity using a hepatocellular carcinoma model. Molecular Cancer Therapeutics. ,vol. 2, pp. 557- 561 ,(2003)
S. Edwards, K. Price, D.H. Adams, Vitronectin induces migration of activated T lymphocytes Journal of Hepatology. ,vol. 32, pp. 225- ,(2000) , 10.1016/S0168-8278(00)81190-3
R. Christopher Benyon, Christopher J. Hovell, Marianna Da Gaça, Emma H. Jones, John P. Iredale, Michael J. P. Arthur, Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation Hepatology. ,vol. 30, pp. 977- 986 ,(1999) , 10.1002/HEP.510300431
Yuka Akashi, Chizu Koreeda, Shigeki Enomoto, Shozo Uchiyama, Takako Mizuno, Yasuko Shiozaki, Yoshiko Sameshima, Kyoichi Inoue, Prognosis of unresectable hepatocellular carcinoma: An evaluation based on multivariate analysis of 90 cases Hepatology. ,vol. 14, pp. 262- 268 ,(1991) , 10.1002/HEP.1840140210
Massimo Pinzani, Novel insights into the biology and physiology of the Ito cell Pharmacology & Therapeutics. ,vol. 66, pp. 387- 412 ,(1995) , 10.1016/0163-7258(94)00072-B
Riko Ogata, Takuji Torimura, Motoaki Kin, Takato Ueno, Yukio Tateishi, Ryoko Kuromatsu, Yoshihiro Shimauchi, Masaharu Sakamoto, Seisyu Tamaki, Michio Sata, Kyuichi Tanikawa, Increased expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 with tumor dedifferentiation in hepatocellular carcinomas Human Pathology. ,vol. 30, pp. 443- 450 ,(1999) , 10.1016/S0046-8177(99)90121-1
R. Christopher Benyon, Michael J.P. Arthur, Extracellular matrix degradation and the role of hepatic stellate cells. Seminars in Liver Disease. ,vol. 21, pp. 373- 384 ,(2001) , 10.1055/S-2001-17552
Yasunori Tsuchiya, Shigeaki Sawada, Kazuhiro Tsukada, Ikuo Saiki, A new pseudo-peptide of Arg-Gly-Asp (RGD) inhibits intrahepatic metastasis of orthotopically implanted murine hepatocellular carcinoma. International Journal of Oncology. ,vol. 20, pp. 319- 324 ,(2002) , 10.3892/IJO.20.2.319